Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec)

Go back to Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec)
Amgen Inc (NASDAQ: AMGN) Delayed: 410.14 +4.10 (1.01%)
Previous Close $406.04    52 Week High $176.85 
Open $408.25    52 Week Low $133.64 
Day High $410.52    P/E 61.77 
Day Low $404.19    EPS $6.64 
Volume 554,432